Omega 3 Polyunsaturated Fatty Acids Supplementation and Blood Pressure Levels in Hypertriglyceridemic Patients with Untreated Normal-High Blood Pressure and With or Without Metabolic Syndrome: A Retrospective Study

REFERENCES

• Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975;28:958–966.
   PubMed Web of Science ®Google Scholar
• Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: The Alaska Siberia Project. Int J Circumpolar Health 2005;64(4):396–408.
   PubMedGoogle Scholar
• Mozaffarian D, Longstreth WT Jr, Lemaitre RN, Fish consumption and stroke risk in elderly individuals: The cardiovascular health study. Arch Intern Med 2005;165(2):200–206.
   PubMed Web of Science ®Google Scholar
• Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC, Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 2006;151(4):857–862.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Taylor DS, Yu-Poth S, Polyunsaturated PUFAs in the food chain in the United States. Am J Clin Nutr 2000;71:179S–188S.
   PubMed Web of Science ®Google Scholar
• Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother 2008;9(7):1237–1248.
   PubMed Web of Science ®Google Scholar
• Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493–1499.
   PubMed Web of Science ®Google Scholar
• Borghi C, Cicero AFG. Blood pressure modulating properties of omega-3 polyunsaturated fatty acids (PUFA). Another PUFA heart protective effect? High Blood Press Cardiov Prev 2007;14(2):1–7.
   Google Scholar
• Mancia G, De Backer G, Dominiczak A, ESH-ESC Task Force on the Management of Arterial Hypertension: 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007;25(9):1751–1762.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Merz CN, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110(2):227–239.
   PubMed Web of Science ®Google Scholar
• Pickering TG, Hall JE, Appel LJ, Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005;111(5):697–716.
   PubMed Web of Science ®Google Scholar
• Derosa G, Fogari E, Cicero AFG, Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin. Hypertens Res 2007;30(5):387–394.
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Harris WS. Appel LJ for the Nutrition Committee. AHA scientific statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747–2757.
   PubMed Web of Science ®Google Scholar
• Wang C, Harris WS, Chung M, n-3. fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary- prevention studies: A systematic review. Am J Clin Nutr 2006;84(1):5–17.
   PubMed Web of Science ®Google Scholar
• Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83(6 suppl):1505S–1519S.
   PubMed Web of Science ®Google Scholar
• Kim JI, Tsujino T, Fujioka Y, Saito K, Yokoyama M. Bezafibrate improves hypertension and insulin sensitivity in humans. Hypertens Res 2003;26(4):307–313.
   PubMed Web of Science ®Google Scholar
• Tomiyama H, Takazawa K, Osa S, Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia? A preliminary study. Hypertens Res 2005;28(8):651–655.
   PubMed Web of Science ®Google Scholar
• Engler MM, Engler MB, Pierson DM, Molteni LB, Molteni A. Effects of docosahexaenoic acid on vascular pathology an reactivity in hypertension. Exp Biol Med 2003;228:299–307.
   Web of Science ®Google Scholar
• Damsgaard CT, Frøkiaer H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 2008;138(6):1061–1066.
   PubMed Web of Science ®Google Scholar
• Barre DE. The role of consumption of alpha-linilenic, eicosapentaenoic and docoshaexaenoic acids in human metabolic syndrome and type 2 diabetes: a mini-review. J Oleo Sci 2007;56(7):319–325.
   PubMedGoogle Scholar
• Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 2007;50(2):250–258.
   PubMed Web of Science ®Google Scholar
• Rossi R, Nuzzo A, Origliani G, Modena MG. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension 2008;52(5):865–872.
   PubMed Web of Science ®Google Scholar
• Tomiyama H, Takazawa K, Osa S, Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia? A preliminary study. Hypertens Res 2008;372(9645):1223–1230.
   Google Scholar
• GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet 2008;372(9645):1223–1230.
   PubMed Web of Science ®Google Scholar
• Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 2006;33(9):842–846.
   PubMed Web of Science ®Google Scholar
• Borghi C. Interactions between hypercholesterolemia and hypertension: Implications for therapy. Curr Opin Nephrol Hypertens 2002;11(5):489–496.
   PubMed Web of Science ®Google Scholar
• Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A. Brisighella Heart Study Working Party. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 2004;148(2):285–292.
   PubMed Web of Science ®Google Scholar